Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?
about
Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia.Acute myeloid leukemia: advancing clinical trials and promising therapeutics.Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients.Acute Myeloid Leukemia: Advancements in Diagnosis and Treatment.Unleashing the immune response against childhood solid cancers.DNA Methylation Events as Markers for Diagnosis and Management of Acute Myeloid Leukemia and Myelodysplastic Syndrome.Treatment of relapsed/refractory acute myeloid leukaemia in adults.Building upon the success of CART19: chimeric antigen receptor T cells for hematologic malignancies.Novel Therapies for Myelofibrosis.
P2860
Q33643108-3D179DF1-76BF-4AAD-9517-B6667065D364Q37221579-845E6930-5750-4EC5-B6D5-8DD061174C1EQ37545824-7A99B27D-E460-44C6-8B5E-CEEC67B13544Q37615574-40589042-6874-4F9E-B680-BD861C8CE606Q39224315-852962AD-8E37-458E-B1F0-4853C578ECA0Q42361215-8A00F9F1-1EB9-44C5-843B-40B6E5B0DE70Q47741553-1982CFFC-056C-49E7-951A-2AE6518983E4Q48255324-A8922C68-A333-4786-90F7-8433AAF69C1BQ52817185-2B5458EC-13C8-40E8-86B8-5C029A712C49
P2860
Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Antigen-specific immunotherapy ...... and where do we go from here?
@en
type
label
Antigen-specific immunotherapy ...... and where do we go from here?
@en
prefLabel
Antigen-specific immunotherapy ...... and where do we go from here?
@en
P2860
P1476
Antigen-specific immunotherapy ...... and where do we go from here?
@en
P2093
Armin Rashidi
Roland B Walter
P2860
P304
P356
10.1586/17474086.2016.1142868
P577
2016-01-16T00:00:00Z